Spots Global Cancer Trial Database for radioembolization
Every month we try and update this database with for radioembolization cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Prospective Post Y90 Liver Hypertrophy | NCT02783261 | Hepatocellular ... Liver Hypertrop... | CT volumetric m... | 21 Years - 99 Years | Singapore General Hospital | |
| Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma. | NCT05451862 | Hepatocellular ... | Holmium-166 tre... Holmium-166 wor... | 18 Years - | Terumo Europe N.V. | |
| Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer | NCT03028311 | Metastatic Live... Stage IV Liver ... Stage IVA Liver... Stage IVB Liver... | Angiography Computed Tomogr... Planar Imaging Radioembolizati... Single Photon E... Technetium Tc-9... Yttrium Y 90 Re... | 18 Years - | M.D. Anderson Cancer Center | |
| Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma | NCT02724436 | Hepatocellular ... Radioembolizati... | TACE radioembolizati... | 17 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
| Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver | NCT02288910 | Hepatocellular ... Metastatic Carc... | 18 Years - | Rush University Medical Center | ||
| Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer | NCT06079242 | Colorectal Neop... | Resin microsphe... | 18 Years - | GrandPharma (China) Co., Ltd. | |
| Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study) | NCT04833517 | Prostate Cancer... Castration Resi... Advanced Prosta... | 18 Years - | Universität des Saarlandes | ||
| Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable HCC and mCRC | NCT04926376 | Hepatocellular ... Metastatic Colo... Liver Cancer | Eye90 Microsphe... | 18 Years - 99 Years | ABK Biomedical | |
| Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) | NCT05953337 | Hepatocellular ... Hepatocellular ... Liver Cancer | EYE90 Microsphe... | 18 Years - 99 Years | ABK Biomedical | |
| Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma | NCT00910572 | Hepatocellular ... Liver Cancer | Yttrium-90 micr... | 18 Years - 80 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Impact of Y90 Radiation Segmentectomy on HCC | NCT03248375 | Hepatocellular ... | Radiation Segme... | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Radiation Major Hepatectomy to Selectively Treat Large Unifocal Hepatocellular Carcinoma | NCT06178198 | Hepatocellular ... | Ablative radioe... | 18 Years - | Seoul National University Hospital | |
| Radioembolization in Elderly/ Fragile Patients With mCRC | NCT05092880 | Colorectal Canc... | radioembolizati... Standard of car... | 18 Years - | UMC Utrecht | |
| Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere® | NCT03203837 | Hepatocellular ... | Plasma collecti... | 18 Years - | Northwestern University | |
| Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma | NCT00910572 | Hepatocellular ... Liver Cancer | Yttrium-90 micr... | 18 Years - 80 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres | NCT02859064 | Neuroendocrine ... Gastrointestina... Carcinoid Tumor... | Lanreotide Y-90 microspher... | 18 Years - | SCRI Development Innovations, LLC | |
| Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCC | NCT04124991 | Hepatocellular ... | Durvalumab Radioembolizati... | 19 Years - | Seoul National University Hospital | |
| Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma | NCT00910572 | Hepatocellular ... Liver Cancer | Yttrium-90 micr... | 18 Years - 80 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| 90Y Transarterial Radioembolization (TARE) Plus Gemcitabine and Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma | NCT02512692 | Intrahepatic Ch... | SIR-Spheres mic... Gemcitabine Cisplatin | 18 Years - | Medical University of South Carolina | |
| Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION | NCT01383746 | Cholestasis, Pr... | Yttrium microsp... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma | NCT02724436 | Hepatocellular ... Radioembolizati... | TACE radioembolizati... | 17 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
| Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort | NCT06334965 | Hepatocellular ... Radioembolizati... | Simultaneous 18... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver | NCT01686880 | Hepatocellular ... Liver Cirrhosis | Sirsphere trans... | 18 Years - | Jules Bordet Institute | |
| Safety and Feasibility of Radioembolization Using Ho-166 in Patients With Unresectable Hepatocellular Carcinoma | NCT05643391 | Hepatocellular ... | Radioembolizati... | 18 Years - | Erasme University Hospital | |
| Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres | NCT02859064 | Neuroendocrine ... Gastrointestina... Carcinoid Tumor... | Lanreotide Y-90 microspher... | 18 Years - | SCRI Development Innovations, LLC | |
| Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients | NCT06142344 | Liver Metastase... Breast Cancer | Quiremspheres™ | 18 Years - | The Netherlands Cancer Institute | |
| Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases | NCT02195011 | Colorectal Neop... | SIR-Spheres Regorafenib | 18 Years - | SCRI Development Innovations, LLC | |
| Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial | NCT06432036 | Stage I Renal C... Stage II Renal ... | Angiogram Biospecimen Col... Computed Tomogr... Radioembolizati... Single Photon E... Survey Administ... Yttrium Y 90 Gl... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) | NCT05953337 | Hepatocellular ... Hepatocellular ... Liver Cancer | EYE90 Microsphe... | 18 Years - 99 Years | ABK Biomedical | |
| Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE | NCT04150874 | Hepatocellular ... Liver Cancer | Lumason® | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases | NCT03802747 | Colorectal Canc... | Durvalumab Durvalumab and ... Y-90 Selective ... Stereotactic Bo... | 18 Years - | University of Colorado, Denver | |
| MRI-guided Holmium-166 Radioembolization | NCT05609448 | Primary Liver C... Non-Resectable ... | MRI-guided radi... | 18 Years - | Radboud University Medical Center | |
| Radioembolization in Elderly/ Fragile Patients With mCRC | NCT05092880 | Colorectal Canc... | radioembolizati... Standard of car... | 18 Years - | UMC Utrecht | |
| Impact of Y90 Radiation Segmentectomy on HCC | NCT03248375 | Hepatocellular ... | Radiation Segme... | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Definitive Therapy for Oligometastatic Solid Malignancies | NCT01898962 | Stage IV or Rec... | Complete Surgic... Stereotactic Ra... Ablative extern... Subtotal surgic... Radioembolizati... | 18 Years - | Rocky Mountain Cancer Centers | |
| Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases | NCT02602327 | Colon Cancer Rectal Cancer Liver Metastase... | Tas-102 SIR-Sphere | 18 Years - | University of California, San Francisco | |
| Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial | NCT06432036 | Stage I Renal C... Stage II Renal ... | Angiogram Biospecimen Col... Computed Tomogr... Radioembolizati... Single Photon E... Survey Administ... Yttrium Y 90 Gl... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere® | NCT03203837 | Hepatocellular ... | Plasma collecti... | 18 Years - | Northwestern University | |
| Definitive Therapy for Oligometastatic Solid Malignancies | NCT01898962 | Stage IV or Rec... | Complete Surgic... Stereotactic Ra... Ablative extern... Subtotal surgic... Radioembolizati... | 18 Years - | Rocky Mountain Cancer Centers | |
| Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study | NCT02067988 | Neuroendocrine ... | Holmium-166 mic... | - | UMC Utrecht | |
| Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients | NCT06142344 | Liver Metastase... Breast Cancer | Quiremspheres™ | 18 Years - | The Netherlands Cancer Institute | |
| Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer | NCT06079242 | Colorectal Neop... | Resin microsphe... | 18 Years - | GrandPharma (China) Co., Ltd. | |
| Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver | NCT01686880 | Hepatocellular ... Liver Cirrhosis | Sirsphere trans... | 18 Years - | Jules Bordet Institute | |
| Prospective Post Y90 Liver Hypertrophy | NCT02783261 | Hepatocellular ... Liver Hypertrop... | CT volumetric m... | 21 Years - 99 Years | Singapore General Hospital | |
| Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer | NCT03028311 | Metastatic Live... Stage IV Liver ... Stage IVA Liver... Stage IVB Liver... | Angiography Computed Tomogr... Planar Imaging Radioembolizati... Single Photon E... Technetium Tc-9... Yttrium Y 90 Re... | 18 Years - | M.D. Anderson Cancer Center | |
| Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors | NCT04315883 | Hepatoblastoma Hepatocellular ... Rhabdoid Tumor ... Undifferentiate... Pediatric Liver... Liver Tumors | Quality of Life... Transarterial R... | 0 Years - 21 Years | Nemours Children's Clinic | |
| Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma | NCT00910572 | Hepatocellular ... Liver Cancer | Yttrium-90 micr... | 18 Years - 80 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
